Resistance to Tyrosine Kinase Inhibitors
The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
| Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells
- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer
- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview
- Resistance to FLT3 Inhibitors
- Resistance to ALK inhibitors
- Resistance to Angiokinase Inhibitors
- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors.
